We’re experiencing issues for some mobile devices with our ARTG dataset filter function. We apologise for any inconvenience while we work to fix this.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Committees and advisory bodies (152)
- Scheduling (national classification system) (58)
- Manufacturing (31)
- Unique Device Identification (UDI) hub (25)
- Safety monitoring and information (18)
- Compliance and enforcement (16)
- Clinical trials (13)
- Vaping hub (9)
- Legislation (8)
- Advertising (7)
- Shortages and supply disruptions (6)
- Labelling and packaging (5)
- Medicinal cannabis hub (5)
- Breast implant hub (2)
- Cosmetics (1)
- Import and export (1)
- Sunscreens (1)
Search
414 result(s) found, displaying 176 to 200
-
PresentationsInformation for manufacturers, sponsors and users of the UDI data on how to access the AusUDID Sandpit
-
-
Committee meetingsThe 35th meeting of the Advisory Committee on Vaccines (ACV), August 2022.
-
WebinarsInformation for manufacturers, sponsors and users of UDI data on how to access the AusUDID Sandpit.
-
PresentationsTo raise awareness and engage with potential website users about the TGA website redevelopment and release.
-
Committee meetingsThe 34th meeting of the Advisory Committee on Vaccines (ACV), July 2022.
-
Committee meetingsThe 38th meeting of the Advisory Committee on Medicines Scheduling (ACMS #38), June 2022.
-
Committee meetingsThe 34th meeting of the Advisory Committee on Chemicals Scheduling (ACCS #34), June 2022.
-
PresentationsInformation for manufacturers, sponsors and users of UDI data on how to access the AusUDID Sandpit.
-
Committee meetingsThe 31st joint meeting of the Advisory Committees on Medicines Scheduling and Chemicals Scheduling (Joint ACMS-ACCS #31), June 2022.
-
-
PresentationsSignificant safety issue reporting - Changes to the Pharmacovigilance guidelines for sponsors.
-
PresentationsImproving healthcare with data collected from medicine and vaccine adverse event reporting.
-
PresentationsReal world evidence in the regulation of medical devices.
-
PresentationsA presentation on current activities, collaborations, and performance of the Prescription Medicine Authorisation Branch.
-
PresentationsPost Market Surveillance - Considerations for medical device sponsors.
-
PresentationsThe increasing availability of Real World Evidence presents opportunities to improve treatments and repurpose medicines.
-
PresentationsUpdates on regulatory framework and key activities from the TGA's Medical Devices Authorisation Branch.
-
PresentationsUpdates on regulatory pathways for gene therapy products in Australia.
-
PresentationsUpdates on key activities for the TGA's Manufacturing Quality Branch.
-
PresentationsUpdates on current activities and focus areas for the Complementary and Over the Counter Medicines Branch.
-
PresentationsLessons learnt from COVID-19 to improve future vaccine development.
-
PresentationsCurrent progress in establishing the Australian Unique Device Identification (UDI) System.
-
PresentationsCurrent considerations for regulating the design and development of software based medical devices.
-
PresentationsPatient-Matched Medical Devices (PMMDs) - key regulatory considerations.